scholarly journals The Value of Renal Biopsy in Non-Insulin-Dependent Diabetes Mellitus in Singapore over the Past Two Decades

2020 ◽  
Vol 6 (4) ◽  
pp. 284-298
Author(s):  
Keng Thye Woo ◽  
Choong Meng Chan ◽  
Cynthia Lim ◽  
Jason Choo ◽  
Yoke Mooi Chin ◽  
...  
1994 ◽  
Vol 40 (4) ◽  
pp. 61-64
Author(s):  
Ye. V. Trofimenko ◽  
N. B. Lebedev ◽  
N. V. Gubanov ◽  
Ye. N. Zlobina ◽  
I. I. Dedov

Insulin-dependent diabetes mellitus (T1DM) is one of the most important problems of our time. This disease plays a significant role in the structure of chronic childhood pathology, leads to severe complications that invalidate a person, and significantly increases mortality at a young age. The study of the incidence of T1DM (the number of new cases of T1DM in a certain population within 1 year) allows you to get answers to a number of questions on its etiology and pathogenesis, to solve the problems of the need to allocate material resources for the organization of preventive and therapeutic measures. Information on the incidence of T1DM in the world applies in most cases to people under the age of 15 years, data for the age group up to 1820 years of age are less common. Epidemiological studies in various countries show an increase in the incidence of T1DM in children. This is shown by the example of Norway, the USA, Finland, Denmark from the 20s of our century, England - from the 50s and other countries over the past 20 years. It is possible to reliably distinguish a true increase in the incidence from an improvement in the detection of diabetes only on the basis of standardized epidemiological studies for certain periods of time. Many countries have compiled national childhood diabetes registries. Thus, in a number of countries standardized information on sex and age was obtained on the incidence of children with T1DM for at least 10 years, divided into 5-year periods. According to these data, the incidence rate has increased in the vast majority of countries over the past 10-20 years. It is noteworthy that the change, namely, an increase in the incidence of type 1 diabetes mellitus in children, is uneven. In some regions of the world, this indicator remained virtually unchanged over fairly long periods of time.


1996 ◽  
Vol 76 (03) ◽  
pp. 328-332 ◽  
Author(s):  
Bernd Jilma ◽  
Peter Fasching ◽  
Christine Ruthner ◽  
Anna Rumplmayr ◽  
Sabine Ruzicka ◽  
...  

SummaryBased on findings that showed increased P-selectin expression on platelets and on choroidal microvessels of patients with insulin dependent diabetes mellitus (IDDM), we hypothesized that also plasma concentrations of circulating (c)P-selectin would be increased in these patients.The aim of this study was to compare the plasma levels of cP-selec-tin between non-smoking patients with IDDM, treated with an intensified insulin therapy, and healthy controls. The study design was prospective, cross-sectional and analyst-blinded. Subjects were matched individually for sex, age and body mass index. Plasma levels of cP-selectin and of von Willebrand antigen (vWF-Ag) were determined by enzyme linked immunoassays.Forty-two pairs were available for intergroup comparison. Median plasma concentrations of cP-selectin in patients with IDDM (285 ng/ml; interquartile range: 233-372) were on average 21% higher than those of controls (236 ng/ml; interquartile range: 175-296; p = 0.004). Also, median plasma levels of vWF-Ag were 10% higher in patients (96 U/dl; interquartile range: 82-127) than controls (87 U/dl; interquartile range: 70-104; p = 0.025). There was no correlation between plasma concentrations of cP-selectin and vWF-Ag levels in either group (p ώ0.05).In conclusion, our results of increased cP-selectin levels are in line with increased P-selectin expression on platelets and on choroidal microvessels found in patients with IDDM. In view of the currently developed small molecule inhibitors of cell adhesion molecules, these independent observations together may provide a sound rationale to select P-selectin as a target for treating or preventing IDDM-associated micro- or macrovascular complications.


Diabetes ◽  
1986 ◽  
Vol 35 (2) ◽  
pp. 139-142 ◽  
Author(s):  
S. Srikanta ◽  
A. T. Ricker ◽  
D. K. McCulloch ◽  
J. S. Soeldner ◽  
G. S. Eisenbarth ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document